Annual Drug Patent Expirations for FOLOTYN
Folotyn is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FOLOTYN.
This drug has thirty-nine patent family members in twenty-three countries.
The generic ingredient in FOLOTYN is pralatrexate. One supplier is listed for this compound. Additional details are available on the pralatrexate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com